We are live on ! Find out more
GC

Gratus Capital Portfolio holdings

AUM $2.5B
1-Year Est. Return 32.89%
This Fund
S&P 500
This Quarter Est. Return
+1.1%
1 Year Est. Return
+32.89%
3 Year Est. Return
+51.43%
5 Year Est. Return
+136.95%
10 Year Est. Return
–
AUM
$680M
AUM Growth
+$224M
Cap. Flow
+$222M
Cap. Flow %
32.67%
Top 10 Hldgs %
44.16%
Holding
182
New
111
Increased
38
Reduced
20
Closed
5

Top Buys

Rank Stock Value
1
VAL
Valspar
VAL
+$8.08M
2
DHR icon
Danaher
DHR
+$7.52M
3
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$6.44M
4
GGG icon
Graco
GGG
+$6.38M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$6.38M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$6.37M
2
MDT icon
Medtronic
MDT
+$2.22M
3
SCHD icon
Schwab US Dividend Equity ETF
SCHD
+$2.08M
4
DD icon
DuPont de Nemours
DD
+$2.06M
5
PWV icon
Invesco Large Cap Value ETF
PWV
+$1.34M

Sector Composition

Rank Sector Weight
1 Consumer Staples 34.55%
2 Financials 10.83%
3 Healthcare 10.25%
4 Industrials 9.41%
5 Technology 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COKE icon
76
Coca-Cola Consolidated
COKE
$12.3B
$2.04M 0.3%
+138,670
New +$2.03M
WTM icon
77
White Mountains Insurance
WTM
$5.47B
$2.04M 0.3%
+2,427
New +$1.98M
BBBY
78
DELISTED
Bed Bath & Beyond Inc
BBBY
$1.92M 0.28%
+44,430
New +$2.01M
AAP icon
79
Advance Auto Parts
AAP
$3.37B
$1.85M 0.27%
+11,476
New +$1.77M
BNS icon
80
Scotiabank
BNS
$106B
$1.83M 0.27%
+37,400
New +$1.84M
CLC
81
DELISTED
Clarcor
CLC
$1.83M 0.27%
+30,028
New +$1.76M
TXN icon
82
Texas Instruments
TXN
$255B
$1.71M 0.25%
+27,339
New +$1.63M
GSK icon
83
GSK
GSK
$103B
$1.67M 0.25%
30,777
+26,587
+635% +$1.4M
PFE icon
84
Pfizer
PFE
$140B
$1.61M 0.24%
+48,294
New +$1.54M
EGP icon
85
EastGroup Properties
EGP
$11.5B
$1.61M 0.24%
+23,370
New +$1.48M
AYI icon
86
Acuity Brands
AYI
$9.88B
$1.56M 0.23%
+6,283
New +$1.57M
NVS icon
87
Novartis
NVS
$295B
$1.53M 0.22%
+20,693
New +$1.43M
CPB icon
88
Campbell Soup
CPB
$6.51B
$1.53M 0.22%
+22,934
New +$1.44M
INTC icon
89
Intel
INTC
$466B
$1.52M 0.22%
46,323
+40,017
+635% +$1.25M
CVX icon
90
Chevron
CVX
$388B
$1.51M 0.22%
14,421
+9,337
+184% +$939K
NBN icon
91
Northeast Bank
NBN
$1.11B
$1.49M 0.22%
+132,544
New +$1.46M
CAH icon
92
Cardinal Health
CAH
$53.4B
$1.41M 0.21%
+18,078
New +$1.44M
KMB icon
93
Kimberly-Clark
KMB
$36.4B
$1.37M 0.2%
9,958
+7,544
+313% +$987K
BMY icon
94
Bristol-Myers Squibb
BMY
$127B
$1.37M 0.2%
+18,592
New +$1.31M
STI
95
DELISTED
SunTrust Banks, Inc.
STI
$1.35M 0.2%
+32,868
New +$1.34M
GOOG icon
96
Alphabet (Google) Class C
GOOG
$3.9T
$1.29M 0.19%
+37,200
New +$1.34M
ADP icon
97
Automatic Data Processing
ADP
$100B
$1.23M 0.18%
+13,384
New +$1.18M
RES icon
98
RPC Inc
RES
$1.24B
$1.19M 0.17%
+76,335
New +$1.12M
PM icon
99
Philip Morris
PM
$301B
$1.16M 0.17%
11,400
+4,542
+66% +$453K
WMT icon
100
Walmart Inc
WMT
$871B
$1.16M 0.17%
+47,445
New +$1.1M
2 3
4
5 6

Similar funds

LFDLE
La Financiere de L'Echiquier Paris, France $2.29B AUM 37.29% 1-Year Est. Return
CDH
Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return
AT
Arvest Trust Bartlesville, Oklahoma $1.68B AUM 14.24% 1-Year Est. Return
BPCA
Bank Pictet & Cie (Asia) Singapore $1.57B AUM 25.56% 1-Year Est. Return
HIG
Herr Investment Group Austin, Texas $1.5B AUM 29.27% 1-Year Est. Return
H
HoyleCohen San Diego, California $1.32B AUM 27.05% 1-Year Est. Return
PRIG
Payden & Rygel Investment Group Los Angeles, California $1.24B AUM
PO
Private Ocean San Rafael, California $1.13B AUM 11.01% 1-Year Est. Return

Gratus Capital's Q2 2016 Portfolio in Review

As of Q2 2016, Gratus Capital held 182 positions worth $680M, up 49% from $456M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Gratus Capital deployed $222M of net new capital in Q2 2016, opening 111 new positions and adding to 38 existing holdings. Its largest new stake was Valspar: 75,300 shares worth $8.13M.

By sector, the portfolio is most concentrated in Consumer Staples at 35% of assets, down from 47% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Medtronic, an estimated $2.22M trimmed.

  • Gratus Capital's largest Q2 2016 buy was Valspar: 75,300 shares worth $8.13M.
  • Gratus Capital added most to Berkshire Hathaway Class B in Q2 2016, an estimated $6.38M increase.
  • Gratus Capital's biggest Q2 2016 reduction was Medtronic, cutting an estimated $2.22M.
  • Gratus Capital fully exited AbbVie in Q2 2016, selling an estimated $6.37M.
  • Gratus Capital's ten largest holdings make up 44% of its $680M portfolio in Q2 2016.
  • Gratus Capital opened 111 new positions and closed 5 in Q2 2016.
  • Gratus Capital's portfolio value rose 49% quarter-over-quarter to $680M.

Based on Gratus Capital's 13F filing for Q2 2016, filed 3 Aug 2016.